Clinical Trial Update: Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of etodolac and propranolol in patients with clinically progressive prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Etodolac (Etodolac)
• Propranolol (propranolol)

Snippet

Sponsor: Vicus Therapeutics | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED